Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Knee. 2022 Dec 16;40:270–282. doi: 10.1016/j.knee.2022.11.024

Table 3.

PT-STRONG intervention outcome measures.

Participant no. 2 Participant no. 3 Participant no. 6
Outcome measure MD C95 Baseline Post-test Difference Baseline Post-test Difference Baseline Post-test Difference
Knee extension force
 Seated 90°, kg 1.98 13.02a 10.75a −17.42% 2.68 2.72 +1.69% 6.26 6.80 +8.67%
 Supine 35°, kg 7.39 5.75 6.88 +19.79%
Muscle thickness
 Vastus lateralis, cm 0.16 1.34 1.16 −12.90% 1.04 1.09 +4.80% 0.75 0.92 +22.38% *
MVIC - vastus lateralis
 RoA50, s−1 1.16 0.71 0.91 +26.85%
 RoA100, s−1 1.16 0.46 0.63 +37.46%
 RoA150, s−1 1.08 0.33 0.82 +146.50%
 RoA200, s−1 0.98 0.25 0.85 +240.04%
MVIC - rectus femoris
 RoA50, s−1 0.99 0.44 0.73 +63.05%
 RoA100, s−1 0.95 0.38 0.71 +85.61%
 RoA150, s−1 0.95 0.49 0.63 +28.80%
 RoA200, s−1 0.83 0.51 0.57 +12.52%
MVIC - knee CCI 0.39 0.42 0.19 55.14%
Step-Up - vastus lateralis
 RoA50, s−1 8.10 6.40 15.74 +145.99%
 RoA100, s−1 3.73 3.82 9.35 +145.06% *
 RoA150, s−1 1.70 2.89 6.48 +124.43% *
 RoA200, s−1 0.57 2.63 4.68 +77.97% *
Step-Up - rectus femoris
 RoA50, s−1 10.60 9.74 16.24 +66.71%
 RoA100, s−1 3.03 5.40 10.18 +88.48% *
 RoA150, s−1 0.67 3.51 6.62 +88.82% *
 RoA200, s−1 0.16 2.90 4.30 +48.47% *
Step-up - knee CCI 0.73 0.66 0.52 20.91%
Timed Up and Down Stairs, s 4.03 15.43 12.38 19.77% 41.92 41.94 +0.05% 15.90 13.55 14.78%
Timed Up and Go, s 0.87 6.82 6.00 12.02% 10.52 9.15 13.02%* 12.33 8.93 27.58%*
9-min Run-Walk, m 76.13 722.99 789.74 +9.23% 531.57 534.92 +0.63% 401.12 456.59 +13.83%

Bold text indicates improvement in outcome measure. CCI, co-contraction index; MVIC, maximum voluntary isometric contractions; RoA, rate of muscle activation.

a

Participant no. 2 had limited knee flexion range of motion; therefore, the strength testing was performed at end-range of knee flexion (baseline: 58°; post-test: 60°).

*

The difference between baseline and post-test exceeded the minimally detectable change (MDC95).